DK166323C - Griseolsyrederivater og farmaceutiske midler indeholdende disse - Google Patents

Griseolsyrederivater og farmaceutiske midler indeholdende disse

Info

Publication number
DK166323C
DK166323C DK513384A DK513384A DK166323C DK 166323 C DK166323 C DK 166323C DK 513384 A DK513384 A DK 513384A DK 513384 A DK513384 A DK 513384A DK 166323 C DK166323 C DK 166323C
Authority
DK
Denmark
Prior art keywords
acid derivatives
griseolic acid
pharmaceutical agents
agents containing
griseolic
Prior art date
Application number
DK513384A
Other languages
Danish (da)
English (en)
Other versions
DK513384D0 (da
DK513384A (da
DK166323B (da
Inventor
Masakatsu Kaneko
Misako Kimura
Yoshinobu Murofushi
Mitsuo Yamazaki
Nobuyoshi Iwata
Fumio Nakagawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of DK513384D0 publication Critical patent/DK513384D0/da
Publication of DK513384A publication Critical patent/DK513384A/da
Publication of DK166323B publication Critical patent/DK166323B/da
Application granted granted Critical
Publication of DK166323C publication Critical patent/DK166323C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Insulating Materials (AREA)
  • Fats And Perfumes (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK513384A 1983-10-28 1984-10-26 Griseolsyrederivater og farmaceutiske midler indeholdende disse DK166323C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20236283 1983-10-28
JP58202362A JPS6094992A (ja) 1983-10-28 1983-10-28 グリゼオ−ル酸誘導体

Publications (4)

Publication Number Publication Date
DK513384D0 DK513384D0 (da) 1984-10-26
DK513384A DK513384A (da) 1985-04-29
DK166323B DK166323B (da) 1993-04-05
DK166323C true DK166323C (da) 1993-08-30

Family

ID=16456245

Family Applications (1)

Application Number Title Priority Date Filing Date
DK513384A DK166323C (da) 1983-10-28 1984-10-26 Griseolsyrederivater og farmaceutiske midler indeholdende disse

Country Status (12)

Country Link
US (1) US4634706A (no)
EP (1) EP0143557B1 (no)
JP (1) JPS6094992A (no)
KR (1) KR930000165B1 (no)
AT (1) ATE39357T1 (no)
CA (1) CA1267408A (no)
DE (1) DE3475714D1 (no)
DK (1) DK166323C (no)
ES (4) ES8604737A1 (no)
FI (1) FI81357C (no)
NO (1) NO164904C (no)
SU (4) SU1600632A3 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783532A (en) * 1983-10-28 1988-11-08 Sankyo Company Limited Process for preparing griseolic acid derivatives
IT1196261B (it) * 1984-09-20 1988-11-16 Pierrel Spa Derivati nucleosidici e purinici 8-sostituiti
EP0319050B1 (en) 1985-04-19 1995-04-12 Sankyo Company Limited Griseolic acid derivatives, their preparation and their use
DK167878B1 (da) * 1985-04-19 1993-12-27 Sankyo Co Griseolsyrederivater
JPH0631307B2 (ja) * 1985-04-27 1994-04-27 三共株式会社 グリゼオ−ル酸誘導体の製法
US5214048A (en) * 1987-05-19 1993-05-25 Nippon Kayaku Kabushiki Kaisha Oxetanocins
JPH0774229B2 (ja) * 1987-12-02 1995-08-09 三共株式会社 グリゼオール酸モノエステル誘導体
US5091431A (en) * 1988-02-08 1992-02-25 Schering Corporation Phosphodiesterase inhibitors
JPH0689020B2 (ja) * 1988-06-30 1994-11-09 三共株式会社 グリゼオール酸のモノエステル誘導体
US4971972A (en) * 1989-03-23 1990-11-20 Schering Corporation Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion
JP3645580B2 (ja) * 1993-10-22 2005-05-11 株式会社フジモト・ブラザーズ グルコースエステル誘導体を含有する脳代謝改善剤
US6291516B1 (en) 1999-01-13 2001-09-18 Curis, Inc. Regulators of the hedgehog pathway, compositions and uses related thereto
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
US7342884B2 (en) * 2002-03-13 2008-03-11 Harmonic, Inc. Method and apparatus for one directional communications in bidirectional communications channel
US20110190192A1 (en) * 2009-12-15 2011-08-04 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
EP4163000B1 (en) * 2021-02-19 2024-04-10 Anhui Jinhe Industrial Co., Ltd. Production apparatus and production method for sucrose-6-ester

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
JPS5668695A (en) * 1979-11-10 1981-06-09 Sankyo Co Ltd Enzyme inhibitor griseolic acid and its preparation
DE3028273A1 (de) * 1980-07-25 1982-02-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Durch purinbasen substituierte 1.4;3.6-dianhydro-hexit-nitrate
JPS60246396A (ja) * 1984-05-22 1985-12-06 Sankyo Co Ltd 酵素阻害物質ジヒドロデスオキシグリゼオ−ル酸及びその塩類

Also Published As

Publication number Publication date
ES8700673A1 (es) 1986-10-16
SU1468421A3 (ru) 1989-03-23
NO844291L (no) 1985-04-29
FI844225A0 (fi) 1984-10-26
NO164904C (no) 1990-11-28
EP0143557A3 (en) 1985-07-03
CA1267408A (en) 1990-04-03
ES8701193A1 (es) 1986-11-16
ES547292A0 (es) 1986-02-16
JPS6094992A (ja) 1985-05-28
KR850003415A (ko) 1985-06-17
US4634706A (en) 1987-01-06
FI81357C (fi) 1990-10-10
KR930000165B1 (ko) 1993-01-11
SU1604158A3 (ru) 1990-10-30
SU1468422A3 (ru) 1989-03-23
FI81357B (fi) 1990-06-29
ES547347A0 (es) 1986-10-16
ES537154A0 (es) 1985-12-01
FI844225L (fi) 1985-04-29
DK513384D0 (da) 1984-10-26
JPH0432837B2 (no) 1992-06-01
SU1600632A3 (ru) 1990-10-15
ES547291A0 (es) 1986-11-16
EP0143557B1 (en) 1988-12-21
DK513384A (da) 1985-04-29
EP0143557A2 (en) 1985-06-05
NO164904B (no) 1990-08-20
DE3475714D1 (en) 1989-01-26
DK166323B (da) 1993-04-05
ES8604981A1 (es) 1986-02-16
ES8604737A1 (es) 1985-12-01
ATE39357T1 (de) 1989-01-15

Similar Documents

Publication Publication Date Title
DK166323C (da) Griseolsyrederivater og farmaceutiske midler indeholdende disse
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
CS782686A2 (en) Method of benzimidazole derivatives production
NO304983B1 (no) Nye fosfinyloksymetylketoner, farmas°ytisk sammensetning og anvendelse derav
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
IT1224405B (it) Composti attivi sul sistema cardiovascolare
ES2058343T3 (es) Piridinas disubstituidas.
FI941863A0 (fi) Oksatsolidonijohdannainen
DK0583578T3 (da) 17-(3-furyl)- og 17-(4-pyridazinyl)-5beta,14beta-androstanderivater med aktivitet på det cardiovaskulære system, fremgangsmåder til deres fremstilling og farmaceutiske præparater indeholdende disse
IS4725A (is) Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa
EP0162715A3 (en) Enzyme-inhibitory griseolic acid derivatives, and their use
ZA877454B (en) Therapeutic agent for the treatment of peptic ulcer disease
ES2160093A1 (es) Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.
JPS5233662A (en) Preparation of n2-naphthalenesulfonyl-alginamides and acid addition sa lts thereof
IT1224404B (it) Composti attivi sul sistema cardiovascolare
IT1245390B (it) Composizione farmaceutica ad attivita' antivirale
GEP19980890B (en) Derivatives of N1-(1,2-Cis-halogeno¬-cyclopropyl) Substituted Pyridonecarbonic Acid
TH4574A (th) 1,3,5-ไตรอาซีน-2,4,6-ไตรโอนที่ถูกแทนที่ด้วยหมู่สามหมู่
SE9304065D0 (sv) New compound

Legal Events

Date Code Title Description
PBP Patent lapsed